Yini eyenzelwe nokuthi ungayisebenzisa kanjani iSoliqua
-Delile
- Intengo nokuthi ungathenga kuphi
- Isetshenziswa kanjani
- Imiphumela emibi engaba khona
- Ngubani ongafanele asebenzise
I-Soliqua ngumuthi wesifo sikashukela oqukethe ingxube ye-insulin glargine ne-lixisenatide, futhi ikhonjisiwe ukwelapha uhlobo lwesifo sikashukela sohlobo 2 kubantu abadala, inqobo nje uma kuhlotshaniswa nokudla okunomsoco nokuvivinya umzimba njalo.
Lo muthi uvame ukukhonjiswa lapho kungenakwenzeka ukulawula amazinga kashukela ngokusebenzisa i-basal insulin noma amanye amakhambi. I-Soliqua ithengiswa ngesirinji esivele yagcwaliswa engasetshenziswa ekhaya futhi ekuvumela ukuthi ulawule umthamo owuphathisiwe, ngokuya ngamanani eglucose egazini.
Intengo nokuthi ungathenga kuphi
ISoliqua yamukelwa yi-Anvisa kepha ayikathengiswa, noma kunjalo, itholakala kumakhemisi ajwayelekile, ngemuva kokwethula incwadi kadokotela, ngesimo samabhokisi anamapeni ama-5 3 mL.
Isetshenziswa kanjani
Umthamo wokuqala weSoliqua kufanele ukhonjiswe ngudokotela we-endocrinologist, ngoba kuya ngenani le-basal insulin esetshenziswe phambilini. Kodwa-ke, imihlahlandlela ejwayelekile iyancoma:
- Umthamo wokuqala wamayunithi we-15, ihora eli-1 ngaphambi kokudla kokuqala kosuku, okungakhuphuka kuze kufike kumayunithi angama-60;
Ipeni ngalinye eligcwaliswe ngaphambili le-Soliqua liqukethe amayunithi angama-300, ngakho-ke, angasetshenziswa kabusha kuze kube sekupheleni komuthi, kunconywa kuphela ukushintsha inaliti ngokusetshenziswa ngakunye.
Bona imiyalo yesinyathelo ngesinyathelo yokusebenzisa kahle ipeni le-insulin ekhaya.
Imiphumela emibi engaba khona
Imiphumela emibi ejwayelekile yokusebenzisa i-Soliqua ifaka ukwehla okuphawulekayo kwamazinga kashukela egazini, isicanucanu, ukuhlanza, isifo sohudo, ukoma komzimba kanye nokushaya isisu.
Ngaphezu kwalokho, kubikwe nezimo zokungezwani komzimba okubomvu nokubomvu nokuvuvukala kwesikhumba, kanye nokulunywa okunzima nokuphefumula kanzima. Kulezi zimo, ukwelashwa kufanele kumiswe ngokushesha.
Ngubani ongafanele asebenzise
I-Soliqua iyaphikiswa kubantu abane-type 1 yesifo sikashukela, i-ketoacidosis yesifo sikashukela, i-gastroparesis, noma enomlando we-pancreatitis. Ngaphezu kwalokho, akufanele futhi isetshenziswe ngokuhambisana nezinye izidakamizwa ezine-lixisenatide noma enye i-GLP-1 receptor agonist.
Endabeni yokuhlaselwa yi-hypoglycemic noma ukuzwela ezingxenyeni zefomula, iSoliqua nayo akufanele isetshenziswe.